LANEIGE SNOW CRYSTAL description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

LANEIGE SNOW CRYSTAL

AMOREPACIFIC

LANEIGESNOW CRYSTAL DUAL FOUNDATIONSPF22/ PA+


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

WARNING LABEL

FOR EXTERNAL USE ONLY.

AVOID CONTACT WITH EYES. DISCONTINUE USE IF SIGNS OF IRRITATION APPEAR,

KEEP OUT OF REACH OF CHILDREN

Active ingredient

ACTIVE INGREDIENTS

EHYLHEXYL METHOXYNNAMATE 5.00%, TITANIUM DIOXIDE 5.82%, ZINC OXIDE 0.98%

Uses

Dual foundation that softly melts away like snow, giving light and watery moisture finish

Dermatologist Tested

30ml / 1.0 FL.OZ. e

AMOREPACIFIC US INC.
270 Sylvan Ave. #255
Englewood Cliffs, NJ 07632

www.laneige.com

INGREDIENTS

WATER, CYCLOPENTASILOXANE, METHYL TRIMETHICONE, TITANIUM DIOXIDE, ETHYLHEXYL METHOXYCINNAMATE, ALCOHOL, DIMETHICONE, LAURYL PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE, BUTYLENE GLYCOL, SODIUM CHLORIDE, DISTEARDIMONIUM HECTORITE, FAGRAEA BERTEROANA FLOWER EXTRACT, AGERATUM CONYZOIDES LEAF EXTRACT, MORINDA CITRIFOLIA LEAF EXTRACT, ZINC OXIDE, POLYMETHYL METHACRYLATE, MICA, DIMETHICONE/PEG-10/15 CROSSPOLYMER, DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER, ACRYLATES/ETHYLHEXYL ACRYLATE/DIMETHICONE METHACRYLATE COPOLYMER, DIMETHICONE/POLYGLYCERIN-3 CROSSPOLYMER, ALUMINUM HYDROXIDE, STEARIC ACID, TRIETHOXYCAPRYLYLSILANE, DISODIUM EDTA, SYNTHETIC FLUORPHLOGOPITE, MANNAN, BEESWAX, POLYGLYCERYL-3 METHYLGLUCOSE DISTEARATE, HYDROXYPROPYL BISPALMITAMIDE MEA, INULIN LAURYL CARBAMATE, PROPYLENE GLYCOL, PEG-40 HYDROGENATED CASTOR OIL, METHYLPARABEN, PROPYLPARABEN, IRON OXIDES (CI77491, CI77492, CI77499), FRAGRANCE

PRINCIPAL DISPLAY PANEL - 30ml Bottle Carton - No. 21

LANEÍGE

SNOW CRYSTAL
DUAL FOUNDATION
SPF22 PA+

30ml / 1.0 FL.OZ.

LANEIGE SNOW CRYSTAL

PRINCIPAL DISPLAY PANEL - 30ml Bottle Carton - No. 23

LANEÍGE

SNOW CRYSTAL
DUAL FOUNDATION
SPF22 PA+

30ml / 1.0 FL.OZ.

LANEIGE SNOW CRYSTAL

PRINCIPAL DISPLAY PANEL - 30ml Bottle Carton - No. 31

LANEÍGE

SNOW CRYSTAL
DUAL FOUNDATION
SPF22 PA+

30ml / 1.0 FL.OZ.

LANEIGE SNOW CRYSTAL

PRINCIPAL DISPLAY PANEL - 30ml Bottle Carton - No. 33

LANEÍGE

SNOW CRYSTAL
DUAL FOUNDATION
SPF22 PA+

30ml / 1.0 FL.OZ.

LANEIGE SNOW CRYSTAL

LANEIGE SNOW CRYSTAL

Octinoxate, TITANIUM DIOXIDE, and ZINC OXIDE LOTION

Product Information

Product Type Human otc drug label Item Code (Source) NDC:43419-857
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.05 mg
titanium dioxide 0.0582 mg
Zinc Oxide Zinc oxide 0.0098 mg

Inactive Ingredients

Ingredient Name Strength
water
BUTYLENE GLYCOL
CYCLOMETHICONE 5
METHYL TRIMETHICONE
ALCOHOL
DIMETHICONE
SODIUM CHLORIDE
MICA
aluminum hydroxide
STEARIC ACID
METHYLPARABEN
PROPYLPARABEN
EDETATE DISODIUM
PHENOXYETHANOL
YELLOW WAX
ETHYLPARABEN
BUTYLPARABEN
isobutylparaben
POLYOXYL 40 HYDROGENATED CASTOR OIL
propylene glycol

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 30 in 1 BOTTLE
2 NDC:43419-857-21 1 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2010-09-15


LANEIGE SNOW CRYSTAL

Octinoxate, TITANIUM DIOXIDE, and ZINC OXIDE LOTION

Product Information

Product Type Human otc drug label Item Code (Source) NDC:43419-858
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.05 mg
titanium dioxide 0.0582 mg
Zinc Oxide Zinc oxide 0.0098 mg

Inactive Ingredients

Ingredient Name Strength
water
BUTYLENE GLYCOL
CYCLOMETHICONE 5
METHYL TRIMETHICONE
ALCOHOL
DIMETHICONE
SODIUM CHLORIDE
MICA
aluminum hydroxide
STEARIC ACID
METHYLPARABEN
PROPYLPARABEN
EDETATE DISODIUM
PHENOXYETHANOL
YELLOW WAX
ETHYLPARABEN
BUTYLPARABEN
isobutylparaben
POLYOXYL 40 HYDROGENATED CASTOR OIL
propylene glycol

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 30 in 1 BOTTLE
2 NDC:43419-858-22 1 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2010-09-15


LANEIGE SNOW CRYSTAL

Octinoxate, TITANIUM DIOXIDE, and ZINC OXIDE LOTION

Product Information

Product Type Human otc drug label Item Code (Source) NDC:43419-859
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.05 mg
titanium dioxide 0.0582 mg
Zinc Oxide Zinc oxide 0.0098 mg

Inactive Ingredients

Ingredient Name Strength
water
BUTYLENE GLYCOL
CYCLOMETHICONE 5
METHYL TRIMETHICONE
ALCOHOL
DIMETHICONE
SODIUM CHLORIDE
MICA
aluminum hydroxide
STEARIC ACID
METHYLPARABEN
PROPYLPARABEN
EDETATE DISODIUM
PHENOXYETHANOL
YELLOW WAX
ETHYLPARABEN
BUTYLPARABEN
isobutylparaben
POLYOXYL 40 HYDROGENATED CASTOR OIL
propylene glycol

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 30 in 1 BOTTLE
2 NDC:43419-859-23 1 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2010-09-15


LANEIGE SNOW CRYSTAL

Octinoxate, TITANIUM DIOXIDE, and ZINC OXIDE LOTION

Product Information

Product Type Human otc drug label Item Code (Source) NDC:43419-860
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 0.05 mg
titanium dioxide 0.0582 mg
Zinc Oxide Zinc oxide 0.0098 mg

Inactive Ingredients

Ingredient Name Strength
water
BUTYLENE GLYCOL
CYCLOMETHICONE 5
METHYL TRIMETHICONE
ALCOHOL
DIMETHICONE
SODIUM CHLORIDE
MICA
aluminum hydroxide
STEARIC ACID
METHYLPARABEN
PROPYLPARABEN
EDETATE DISODIUM
PHENOXYETHANOL
YELLOW WAX
ETHYLPARABEN
BUTYLPARABEN
isobutylparaben
POLYOXYL 40 HYDROGENATED CASTOR OIL
propylene glycol

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 30 in 1 BOTTLE
2 NDC:43419-860-24 1 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2010-09-15


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.